Literature DB >> 11932210

Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers.

S Vejda1, M Cranfield, B Peter, S L Mellor, N Groome, R Schulte-Hermann, W Rossmanith.   

Abstract

Activins are cytokines of the transforming growth factor beta family, which plays a central role in the determination of cell fate and the regulation of tissue balance. Family members are composed of two subunits and this dimerization is critical for liganding their cognate receptors and execution of proper functions. In the current study we focused on the localization of activin betaA, betaB, betaC and betaE subunits in the adult rat and analyzed the composition of putative activin beta dimers. By dissecting tissue distribution of various activins, we found that the liver, in particular the hepatocytes, is the major source for activin betaC and betaE transcripts, since other tissues almost failed to express these isoforms. In sharp contrast, the emergence of activin betaA and betaB appeared ubiquitous. Using a highly selective proteome approach, we were able to identify homo- as well as heterodimers of individual activin subunits, indicating a high redundancy of ligand composition. Certainly, this broad potential to homo- and heterodimerize has to be considered in future studies on activin function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932210     DOI: 10.1677/jme.0.0280137

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  13 in total

1.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.

Authors:  Thomas B Thompson; Teresa K Woodruff; Theodore S Jardetzky
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

Review 2.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

3.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

4.  Liver regeneration and the atrophy-hypertrophy complex.

Authors:  Robin D Kim; Jae Sung Kim; Go Watanabe; Dagmara Mohuczy; Kevin E Behrns
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

5.  Rat activin-betaE mRNA expression during development and in acute and chronic liver injury.

Authors:  Elspeth J Gold; Marcel A Monaghan; Jean S Fleming
Journal:  J Mol Genet Med       Date:  2006-04-12

Review 6.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines.

Authors:  Florian Bergauer; Ansgar Brüning; Naim Shabani; Thomas Blankenstein; Julia Jückstock; Darius Dian; Ioannis Mylonas
Journal:  J Mol Histol       Date:  2009-12-24       Impact factor: 2.611

8.  Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.

Authors:  Ioannis Mylonas; Ansgar Brüning; Naim Shabani; Susanne Kunze; Markus S Kupka
Journal:  Reprod Biol Endocrinol       Date:  2010-11-19       Impact factor: 5.211

9.  Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?

Authors:  K Frost; K Seir; A Lackner; M Grusch; B Grasl-Kraupp; R Schulte-Hermann; C Rodgarkia-Dara
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

10.  Structure and activation of pro-activin A.

Authors:  Xuelu Wang; Gerhard Fischer; Marko Hyvönen
Journal:  Nat Commun       Date:  2016-07-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.